Iris Acquisition Corp

Status: Live Deal
U=S+W/4 W=S@11.5
IPO Proceeds, $M $276.00M
IPO Date Mar 5, 2021
CEO Sumit Mehta
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24 + 3 + 3 + 3 + 3 + 3 + 3 + (3)
IPO Sector General

Not specified

IPO Geography Global
Target Company Liminatus Pharma
Deal Announced Nov 30, 2022
Deal Size, $M $334.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Mar 7, 2024
IRAA IRAAU IRAAW

Sign up for Free Trial

No credit card required

Sign in for more on Iris Acquisition Corp:

  • Structure and cap table
  • 7 directors & officers
  • 27 filings and events
  • 1 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Sumit Mehta 38 Chief Executive Officer
Rohit Nanani 46 Chairman & Director
Lisha Parmar Chief Financial Officer
Omkar Halady Vice President
Richard Peretz 59 Director
Manish Shah Director
Nicholas Fernandez 39 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cantor Fitzgerald BR 24,000,000 units
24,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Filings

Sign in to view 27 filings.

Shareholders

Sign in to view shareholders 13F filing data.